July 15, 2025

Fibrinogen Concentrate Reduces Blood Loss in Surgery

In a phase 3 trial, a purified human fibrinogen concentrate reduced intraoperative blood loss and lowered thromboembolic risks compared with fresh frozen plasma or cryoprecipitate during major surgeries.

Conexiant

July 09, 2025

Recombinant Zoster Vaccine Linked to New-Onset Lupus

Researchers report the first documented case of systemic lupus erythematosus following Shingrix vaccination.

Conexiant

July 09, 2025

Chemotherapy Leaves Long-Lasting DNA Scars in Blood

Chemotherapy, while targeting cancer cells, also leaves a lasting mark on normal blood cells by introducing DNA mutations that can persist for decades.

Conexiant

July 02, 2025

FDA Approves Ready-to-Infuse Vancomycin

Tyzavan is the first FDA-approved vancomycin formulation available at room temperature that requires no compounding, thawing, or dilution, enabling faster treatment in time-critical infections like sepsis.

Conexiant

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

March 21, 2025

Vutrisiran Receives FDA Nod for ATTR Amyloidosis With Cardiomyopathy

The FDA approves vutrisiran (Amvuttra) as the first RNAi therapeutic to reduce cardiovascular events and mortality in adults with transthyretin-mediated (ATTR) amyloidosis with cardiomyopathy.

Conexiant

March 10, 2025

AI Methods Strengthen Real-World Data Reliability

Researchers assessed the impact of AI-driven methods on real-world data reliability, showing improvements in accuracy, completeness, and traceability

Conexiant

June 02, 2025

Restrictive Platelet Thresholds Endorsed in New Guidelines

International experts reviewed decades of data and endorsed lower platelet transfusion thresholds.

Conexiant

March 06, 2025

Early Research Finds Aspirin May Block Cancer Spread by Boosting Immune Response

Preclinical study demonstrates that aspirin may prevent cancer metastasis by inhibiting platelet-produced TXA2, which normally suppresses T-cell immunity against spreading cancer cells.

Conexiant